Low Testosterone: Symptoms Most Men Miss and the Real Facts About TRT

Testosterone is the primary male sex hormone, and its decline with age is a genuine physiological phenomenon with real clinical consequences — but it exists in a medical landscape where under-diagnosis in men with symptomatic deficiency and over-treatment by direct-to-consumer clinics operating without adequate evaluation create two equally significant problems. Low testosterone, or hypogonadism, is present in approximately 2 to 6 percent of men overall and becomes increasingly prevalent with age: studies suggest that approximately 20 percent of men over 60 and 30 percent of men over 70 have biochemically low testosterone levels. Understanding what testosterone does, what symptoms its deficiency produces, how to properly diagnose it, and what the evidence says about treatment helps men and their physicians navigate a topic that is both clinically important and heavily marketed.

What Testosterone Does

Testosterone has effects throughout the body. In reproductive tissues, it maintains sperm production (in concert with FSH), supports erectile function, and drives libido. In muscle, it promotes protein synthesis and muscle fiber hypertrophy, maintaining lean body mass. In bone, it supports bone mineral density — men with longstanding hypogonadism have significantly elevated fracture risk. In the brain, testosterone influences mood, motivation, and cognitive function, particularly spatial cognition and processing speed. In fat tissue, testosterone regulates metabolic activity; low testosterone is associated with increased central adiposity and insulin resistance, creating a bidirectional relationship with metabolic syndrome and type 2 diabetes. Red blood cell production, skin, and hair follicles are also androgen-sensitive. The wide range of testosterone's biological effects is reflected in the breadth of symptoms associated with its deficiency.

Normal Testosterone Ranges

Total testosterone is measured in the morning (levels decline throughout the day due to circadian variation, typically by 30 to 40 percent from peak to nadir) on at least two separate occasions before making a diagnosis of hypogonadism. Normal total testosterone ranges for adult men are typically 300 to 1000 ng/dL, though the lower boundary varies between laboratories, and the Endocrine Society defines hypogonadism as a morning total testosterone consistently below 300 ng/dL in the presence of compatible symptoms. Total testosterone measurement alone is insufficient in some circumstances because approximately 44 to 65 percent of testosterone circulates bound to sex hormone-binding globulin (SHBG) and is biologically inactive. Free testosterone — the fraction not bound to SHBG or albumin — is the biologically active fraction, and should be calculated or measured directly when total testosterone is borderline or when SHBG levels may be altered (as in obesity, where SHBG is suppressed, or in older men, where SHBG rises, making total testosterone an overestimate of bioavailable hormone).

Symptoms of Low Testosterone

The symptoms of hypogonadism are nonspecific, which is part of why the condition is both missed and over-diagnosed. The most specific symptoms for confirmed biochemical hypogonadism — meaning those most predictive of an actual testosterone deficiency rather than other conditions — are reduced morning erections, reduced libido, and gynecomastia (breast tissue development). Other common but less specific symptoms include fatigue, decreased energy, depressed mood, irritability, difficulty concentrating, reduced muscle mass and strength, increased body fat (particularly central), decreased bone density, reduced body and facial hair, decreased ejaculate volume, and impaired fertility. Hot flashes, while more commonly associated with women, can occur in men with significant androgen deficiency.

Because these symptoms overlap significantly with depression, sleep disorders (particularly obstructive sleep apnea), hypothyroidism, diabetes, obesity, and normal aging, testosterone measurement is necessary to confirm the diagnosis — symptoms alone are not sufficient. Simultaneously, treating symptoms of depression or fatigue with TRT without confirming biochemical deficiency is not appropriate clinical practice.

Causes of Low Testosterone

Primary Hypogonadism

Primary hypogonadism originates in the testes themselves — the testes are not producing adequate testosterone despite normal or elevated signals from the pituitary. LH and FSH are elevated (the pituitary is working harder to stimulate an underperforming testis). Causes include Klinefelter syndrome (47,XXY karyotype, the most common cause of primary hypogonadism, present in approximately 1 in 650 males), mumps orchitis, testicular torsion or injury, chemotherapy or radiotherapy to the gonads, and undescended testes.

Secondary Hypogonadism

Secondary (hypogonadotropic) hypogonadism originates in the hypothalamus or pituitary — inadequate signaling drives insufficient testicular testosterone production. LH and FSH are low or inappropriately normal. Causes include pituitary adenoma, hyperprolactinemia, hemochromatosis, chronic illness (particularly liver disease, kidney disease, and HIV/AIDS), obesity (adipose tissue aromatizes testosterone to estrogen and suppresses gonadotropins), type 2 diabetes, obstructive sleep apnea, chronic stress, opioid use (opioids profoundly suppress gonadotropin secretion — opioid-induced hypogonadism is extremely common and underrecognized), glucocorticoid excess, and anabolic steroid use (which suppresses the hypothalamic-pituitary-testicular axis and can require months to recover after cessation).

Late-Onset Hypogonadism and Aging

Total testosterone declines at approximately 1 to 2 percent per year after age 30 to 35. The European Male Aging Study found that approximately 2.1 percent of men aged 40 to 79 had symptomatic late-onset hypogonadism meeting criteria for both biochemical deficiency and specific symptoms. Age-related testosterone decline alone is not inevitably symptomatic and does not automatically warrant treatment — the relationship between testosterone level and symptom threshold is highly individual.

How to Properly Test for Low Testosterone

A proper evaluation includes: two morning total testosterone measurements (before 10 AM, on separate days), free testosterone calculation or measurement if total testosterone is borderline, LH and FSH to distinguish primary from secondary hypogonadism, prolactin (to exclude a prolactinoma as the cause of secondary hypogonadism), complete blood count (baseline for polycythemia monitoring), and assessment for treatable contributing factors including obesity, sleep apnea, thyroid dysfunction, and opioid use. In men under 40 or with clinical features of systemic disease, additional investigation is warranted. A PSA and digital rectal examination are appropriate before initiating TRT in men over 40.

Testosterone Replacement Therapy: Options

Testosterone can be replaced through several delivery routes, each with distinct pharmacokinetic profiles, practical considerations, and side effect patterns.

Intramuscular injections (testosterone cypionate or enanthate, typically 100 to 200 mg every 1 to 2 weeks) are the oldest and least expensive option, but produce peak-and-trough testosterone cycles that some men find cause mood and energy fluctuations. Subcutaneous injections at lower, more frequent doses (every 3 to 5 days) produce more stable levels. Topical gels (AndroGel, Testim, Vogelxo) and creams apply daily, producing relatively stable levels but carrying the risk of transference to partners or children through skin contact — women and children should avoid contact with treated areas until dry or covered. Transdermal patches (Androderm) produce stable levels but have high rates of skin irritation. Testosterone pellets (Testopel), implanted subcutaneously every 3 to 6 months, provide the most stable levels without daily administration but require a minor office procedure and cannot be removed if side effects occur. Oral testosterone undecanoate (Jatenzo, Kyzayla) is an option for men who prefer oral administration; it requires twice-daily dosing with a high-fat meal and has a different lipid profile effect than injectable forms.

Risks of TRT

The risks of TRT are real and require monitoring. Polycythemia (elevated red blood cell count and hematocrit) is the most common significant side effect, occurring in approximately 5 to 10 percent of TRT users; elevated hematocrit above 54 percent increases the risk of venous thromboembolism and stroke and requires dose reduction or treatment interruption. Suppression of the hypothalamic-pituitary-testicular axis occurs with all exogenous testosterone, leading to reduced or absent sperm production — TRT is not an appropriate choice for men who wish to preserve fertility. Testicular atrophy occurs for the same reason. Fluid retention can worsen heart failure or hypertension. Sleep apnea can worsen with TRT. Skin oiliness and acne occur in some users.

The cardiovascular safety of TRT has been debated; the 2024 TRAVERSE trial, a large randomized controlled trial specifically designed to assess cardiovascular outcomes, found no significant increase in major adverse cardiovascular events (MACE) with TRT compared to placebo in men with pre-existing cardiovascular disease or risk factors. This was reassuring data that resolved much of the uncertainty from earlier observational studies. Prostate concerns: TRT does not cause prostate cancer, but testosterone stimulates the growth of pre-existing prostate cancer; PSA monitoring is essential and TRT is contraindicated in men with known or suspected prostate cancer.

Direct-to-Consumer Testosterone Clinics: Caution

The proliferation of telehealth "Low T clinics" that offer testosterone prescriptions based on a single blood draw and a symptom questionnaire, without assessment for reversible causes, without establishing two morning measurements, without considering free testosterone, and without appropriate monitoring, represents a significant clinical problem. Some of these services prescribe TRT to men with total testosterone in the low-normal range who have not had reversible causes (obesity, sleep apnea, opioid use) addressed, and do so without the cardiovascular assessment, prostate evaluation, or regular hematocrit monitoring that responsible TRT prescribing requires. Testosterone is a genuinely useful therapy for men with confirmed symptomatic hypogonadism; it should be prescribed and monitored by clinicians following established guidelines, not dispensed as a subscription wellness product.

When to See a Doctor

If you are experiencing persistent fatigue, reduced libido, erectile dysfunction, mood changes, reduced muscle mass, or loss of morning erections, a proper evaluation that includes morning testosterone measurement, a complete history, and assessment for reversible contributing causes is the appropriate first step. JourneyDoctors connects you with trained specialists from $19. Start a consultation today — no waiting room, no referral needed.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.

Frequently Asked Questions

Can I boost testosterone naturally?

Several modifiable lifestyle factors have meaningful effects on testosterone levels. Weight loss in obese men reliably increases testosterone — an average of 15 to 25 percent improvement has been reported in studies of significant weight loss. Treating obstructive sleep apnea with CPAP increases testosterone in hypogonadal men with OSA. Regular resistance training and adequate sleep (7 to 9 hours) support testosterone levels. Correcting vitamin D deficiency and zinc deficiency if present can produce modest improvements. These interventions are appropriate first steps when testosterone is borderline low and reversible causes are present, and can sometimes normalize levels without requiring TRT.

Does TRT affect fertility?

Yes. Exogenous testosterone suppresses LH and FSH, which drive testicular testosterone production and sperm production. Most men on TRT experience significant reduction in sperm count, and some become azoospermic (no sperm in the ejaculate) while on treatment. For men who wish to father children, TRT is generally avoided; clomiphene citrate (which stimulates endogenous LH and FSH) or human chorionic gonadotropin (hCG, which mimics LH) are preferred as they preserve or improve spermatogenesis while raising testosterone levels. Sperm count typically recovers after stopping TRT, but recovery can take 6 to 24 months and is not guaranteed in all cases.

What testosterone level is considered normal for my age?

The Endocrine Society defines hypogonadism as a morning total testosterone consistently below 300 ng/dL in the context of compatible symptoms, regardless of age. Age-specific reference ranges exist and show a gradual decline with age, but most clinical guidelines recommend treating based on symptoms plus absolute level rather than age-adjusted comparison. A 65-year-old man with symptoms and a total testosterone of 220 ng/dL meets criteria for evaluation; a 65-year-old with no symptoms and a level of 280 ng/dL likely does not require treatment even if the level is below the statistical "normal" range for younger men.

How quickly does TRT work?

Different symptoms respond over different timeframes. Libido often begins to improve within 3 to 4 weeks. Energy and mood may improve over 4 to 6 weeks. Erectile function improvements are typically seen over 3 to 6 months. Muscle mass and strength changes require 3 to 6 months and are enhanced by resistance training. Bone density improvements are measurable at 1 to 2 years. If symptoms have not improved at all after 3 to 6 months of TRT with documented therapeutic testosterone levels, the attribution of symptoms to testosterone deficiency should be reconsidered.

Is TRT the same as anabolic steroid use?

No. Therapeutic TRT aims to restore testosterone levels to the normal physiological range (typically 400 to 700 ng/dL). Anabolic steroid use by athletes and bodybuilders involves supraphysiological doses — often 5 to 20 times or more the testosterone doses used in TRT — frequently combined with other synthetic androgens and growth hormones, with the goal of achieving muscle mass and performance beyond physiological capacity. The risks differ correspondingly: supraphysiological androgen use carries much higher risks of cardiovascular damage, liver toxicity, psychiatric effects, and severe hypothalamic-pituitary-gonadal suppression. Therapeutic TRT monitored by a physician and targeting normal range levels is a fundamentally different intervention.